Development of products obtained by processing human bone tissue for selected applications in tissue engineering and regenerative medicine
Public support
Provider
Ministry of Industry and Trade
Programme
—
Call for proposals
—
Main participants
PrimeCell Advanced Therapy, a.s.
Contest type
OP - EU Operational Programme
Contract ID
MPO 56873/18/61200/3539
Alternative language
Project name in Czech
Vývoj produktů získaných zpracováním lidské kostní tkáně pro vybrané aplikace v tkáňovém inženýrství a regenerativní medicíně
Annotation in Czech
Hlavní náplní projektu je vývoj produktů získaných zpracováním lidské kostní tkáně pro vybrané aplikace v tkáňovém inženýrství a regenerativní medicíně. Tyto produkty budou sloužit jako bioaktivní složka pro materiály a přípravky používané jako kostní výplně určené pro regeneraci kostní tkáně, a to jak v ortopedii, tak ve spondylochirurgii, případně traumatologii a podobně.
Scientific branches
R&D category
VV - Exeperimental development
CEP classification - main branch
EI - Biotechnology and bionics
CEP - secondary branch
FJ - Surgery including transplantology
CEP - another secondary branch
FI - Traumatology and orthopaedics
OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)
20801 - Environmental biotechnology<br>20802 - Bioremediation, diagnostic biotechnologies (DNA chips and biosensing devices) in environmental management<br>20803 - Environmental biotechnology related ethics<br>20901 - Industrial biotechnology<br>20902 - Bioprocessing technologies (industrial processes relying on biological agents to drive the process) biocatalysis, fermentation<br>20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials<br>30211 - Orthopaedics<br>30212 - Surgery<br>30213 - Transplantation<br>30401 - Health-related biotechnology<br>30402 - Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)<br>30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])<br>30404 - Biomaterials (as related to medical implants, devices, sensors)<br>30405 - Medical biotechnology related ethics<br>40401 - Agricultural biotechnology and food biotechnology<br>40402 - GM technology (crops and livestock), livestock cloning, marker assisted selection, diagnostics (DNA chips and biosensing devices for the early/accurate detection of diseases) biomass feedstock production technologies, biopharming<br>40403 - Agricultural biotechnology related ethics
Completed project evaluation
Provider evaluation
U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)
Project results evaluation
The project is focused on the field of regenerative medicine in the field of bone and cartilage damage. The main use of the products obtained within the project, either alone or in combination, due to their osteoinductive and osteoconductive properties, will be mainly in the area of support and increase of the efficiency of tissue regeneration at the site of damage. Both of these products (bioapatite and DBM) will serve as a bioactive component for materials and preparations used as bone fillers intended for bone regeneration in dental implantology, orthopedics or spondylosurgery, or traumatology.
Solution timeline
Realization period - beginning
Nov 30, 2017
Realization period - end
Oct 26, 2021
Project status
U - Finished project
Latest support payment
Mar 11, 2019
Data delivery to CEP
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data delivery code
CEP22-MPO-EG-U
Data delivery date
May 24, 2022
Finance
Total approved costs
13,204 thou. CZK
Public financial support
0 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
4,397 thou. CZK